Feeds › Insider trades
Insider trades
Open-market buys and sells by officers, directors and 10% owners, from SEC Form 4. Usually filed within two business days.
About this data
- What it is
- When a company's officers, directors or owners of more than 10% buy or sell its stock, they must report the trade to the SEC on Form 4. This feed shows purchases and sales on the open market; stock grants, option exercises and shares withheld for tax are left out.
- Who files it
- The insider, usually through the company, within two business days of the trade.
- How current
- We collect new filings throughout the day on SEC business days.
- Worth knowing
- Sales are often routine: insiders sell to diversify, to pay taxes, or under a 10b5-1 plan set up months in advance. A purchase with their own money is less common, which is why many investors pay closer attention to it.
All of this comes from public filings.
Source and freshness · Information, not investment advice (disclaimer).
Open-market trades per day, last 30 days
Purchases Sales
By trade date. Insiders have two business days to file, so the most recent days fill in later.
Latest open-market insider trades
Showing: ticker IDXX
| Traded | Insider | Company | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Nov 4, 2026 | Sharon E. Underberg EVP, GC & Corporate Secretary | IDXX IDEXX Laboratories, Inc. | Sale | 1,055 | $690.02 | $728.0K Sale | Form 4 ↗ |
| Nov 4, 2026 | Sharon E. Underberg EVP, GC & Corporate Secretary | IDXX IDEXX Laboratories, Inc. | Sale | 1,503 | $689.05 | $1.0M Sale | Form 4 ↗ |
| Nov 4, 2026 | Sharon E. Underberg EVP, GC & Corporate Secretary | IDXX IDEXX Laboratories, Inc. | Sale | 6,348 | $688.25 | $4.4M Sale | Form 4 ↗ |
| Nov 4, 2026 | Jonathan Jay Mazelsky Executive Chair of the Board, Director | IDXX IDEXX Laboratories, Inc. | Sale | 331 | $711.95 | $235.7K Sale | Form 4 ↗ |
| Nov 4, 2026 | Jonathan Jay Mazelsky Executive Chair of the Board, Director | IDXX IDEXX Laboratories, Inc. | Sale | 775 | $711.31 | $551.3K Sale | Form 4 ↗ |
| Nov 4, 2026 | Jonathan Jay Mazelsky Executive Chair of the Board, Director | IDXX IDEXX Laboratories, Inc. | Sale | 1,501 | $710.12 | $1.1M Sale | Form 4 ↗ |
| Nov 4, 2026 | Jonathan Jay Mazelsky Executive Chair of the Board, Director | IDXX IDEXX Laboratories, Inc. | Sale | 1,300 | $709.00 | $921.7K Sale | Form 4 ↗ |
| Nov 4, 2026 | Jonathan Jay Mazelsky Executive Chair of the Board, Director | IDXX IDEXX Laboratories, Inc. | Sale | 1,840 | $707.84 | $1.3M Sale | Form 4 ↗ |
| Nov 4, 2026 | Jonathan Jay Mazelsky Executive Chair of the Board, Director | IDXX IDEXX Laboratories, Inc. | Sale | 840 | $707.00 | $593.9K Sale | Form 4 ↗ |
| Nov 4, 2026 | Jonathan Jay Mazelsky Executive Chair of the Board, Director | IDXX IDEXX Laboratories, Inc. | Sale | 240 | $705.59 | $169.3K Sale | Form 4 ↗ |
| Nov 4, 2026 | Jonathan Jay Mazelsky Executive Chair of the Board, Director | IDXX IDEXX Laboratories, Inc. | Sale | 3,950 | $703.45 | $2.8M Sale | Form 4 ↗ |
| Nov 4, 2026 | Jonathan Jay Mazelsky Executive Chair of the Board, Director | IDXX IDEXX Laboratories, Inc. | Sale | 2,136 | $702.21 | $1.5M Sale | Form 4 ↗ |
| Nov 4, 2026 | Jonathan Jay Mazelsky Executive Chair of the Board, Director | IDXX IDEXX Laboratories, Inc. | Sale | 4,540 | $701.36 | $3.2M Sale | Form 4 ↗ |
| Nov 4, 2026 | Jonathan Jay Mazelsky Executive Chair of the Board, Director | IDXX IDEXX Laboratories, Inc. | Sale | 1,667 | $700.33 | $1.2M Sale | Form 4 ↗ |
| Nov 4, 2026 | Jonathan Jay Mazelsky Executive Chair of the Board, Director | IDXX IDEXX Laboratories, Inc. | Sale | 4,075 | $699.33 | $2.8M Sale | Form 4 ↗ |
| Nov 4, 2026 | Jonathan Jay Mazelsky Executive Chair of the Board, Director | IDXX IDEXX Laboratories, Inc. | Sale | 1,945 | $698.26 | $1.4M Sale | Form 4 ↗ |
| Nov 4, 2026 | Michael Lane Executive Vice President | IDXX IDEXX Laboratories, Inc. | Sale | 1,677 | $687.46 | $1.2M Sale | Form 4 ↗ |
| Nov 4, 2026 | Michael Lane Executive Vice President | IDXX IDEXX Laboratories, Inc. | Sale | 2,059 | $689.70 | $1.4M Sale | Form 4 ↗ |
| Nov 4, 2026 | Michael Lane Executive Vice President | IDXX IDEXX Laboratories, Inc. | Sale | 243 | $687.85 | $167.1K Sale | Form 4 ↗ |
| Nov 4, 2026 | Daniel M. Junius Director | IDXX IDEXX Laboratories, Inc. | Sale | 500 | $701.69 | $350.8K Sale | Form 4 ↗ |
| Nov 4, 2026 | Daniel M. Junius Director | IDXX IDEXX Laboratories, Inc. | Sale | 700 | $705.78 | $494.0K Sale | Form 4 ↗ |
| Sep 4, 2026 | Lawrence D. Kingsley Director | IDXX IDEXX Laboratories, Inc. | Sale | 2,203 | $532.08 | $1.2M Sale | Form 4 ↗ |
| Mar 3, 2026 | Nimrata Hunt Executive Vice President | IDXX IDEXX Laboratories, Inc. | Sale | 1,758 | $634.57 | $1.1M Sale | Form 4 ↗ |
| Feb 26, 2026 | Jonathan Jay Mazelsky President and CEO, Director | IDXX IDEXX Laboratories, Inc. | Sale | 2,589 | $663.04 | $1.7M Sale | Form 4 ↗ |
| Feb 26, 2026 | Jonathan Jay Mazelsky President and CEO, Director | IDXX IDEXX Laboratories, Inc. | Sale | 1,000 | $662.16 | $662.2K Sale | Form 4 ↗ |
| Feb 26, 2026 | Jonathan Jay Mazelsky President and CEO, Director | IDXX IDEXX Laboratories, Inc. | Sale | 1,200 | $661.10 | $793.3K Sale | Form 4 ↗ |
| Feb 26, 2026 | Jonathan Jay Mazelsky President and CEO, Director | IDXX IDEXX Laboratories, Inc. | Sale | 2,859 | $659.75 | $1.9M Sale | Form 4 ↗ |
| Feb 26, 2026 | Jonathan Jay Mazelsky President and CEO, Director | IDXX IDEXX Laboratories, Inc. | Sale | 3,660 | $658.92 | $2.4M Sale | Form 4 ↗ |
| Feb 26, 2026 | Jonathan Jay Mazelsky President and CEO, Director | IDXX IDEXX Laboratories, Inc. | Sale | 2,860 | $657.84 | $1.9M Sale | Form 4 ↗ |
| Feb 26, 2026 | Jonathan Jay Mazelsky President and CEO, Director | IDXX IDEXX Laboratories, Inc. | Sale | 1,343 | $656.85 | $882.1K Sale | Form 4 ↗ |
| Feb 26, 2026 | Jonathan Jay Mazelsky President and CEO, Director | IDXX IDEXX Laboratories, Inc. | Sale | 1,488 | $655.85 | $975.9K Sale | Form 4 ↗ |
| Feb 26, 2026 | Jonathan Jay Mazelsky President and CEO, Director | IDXX IDEXX Laboratories, Inc. | Sale | 1,111 | $654.63 | $727.3K Sale | Form 4 ↗ |
| Feb 26, 2026 | Jonathan Jay Mazelsky President and CEO, Director | IDXX IDEXX Laboratories, Inc. | Sale | 1,171 | $653.68 | $765.5K Sale | Form 4 ↗ |
| Feb 26, 2026 | Jonathan Jay Mazelsky President and CEO, Director | IDXX IDEXX Laboratories, Inc. | Sale | 1,669 | $652.49 | $1.1M Sale | Form 4 ↗ |
| Feb 26, 2026 | Jonathan Jay Mazelsky President and CEO, Director | IDXX IDEXX Laboratories, Inc. | Sale | 1,095 | $651.49 | $713.4K Sale | Form 4 ↗ |
| Feb 26, 2026 | Jonathan Jay Mazelsky President and CEO, Director | IDXX IDEXX Laboratories, Inc. | Sale | 1,281 | $650.67 | $833.5K Sale | Form 4 ↗ |
| Feb 26, 2026 | Nimrata Hunt Executive Vice President | IDXX IDEXX Laboratories, Inc. | Sale | 2,693 | $661.54 | $1.8M Sale | Form 4 ↗ |
| Feb 17, 2026 | Michael G. Erickson Executive Vice President | IDXX IDEXX Laboratories, Inc. | Sale | 40 | $629.86 | $25.2K Sale | Form 4 ↗ |
| Feb 17, 2026 | Michael G. Erickson Executive Vice President | IDXX IDEXX Laboratories, Inc. | Sale | 689 | $629.09 | $433.4K Sale | Form 4 ↗ |
| Feb 17, 2026 | Michael G. Erickson Executive Vice President | IDXX IDEXX Laboratories, Inc. | Sale | 2,694 | $628.22 | $1.7M Sale | Form 4 ↗ |
| Feb 17, 2026 | Michael G. Erickson Executive Vice President | IDXX IDEXX Laboratories, Inc. | Sale | 1,288 | $626.26 | $806.6K Sale | Form 4 ↗ |
| Feb 17, 2026 | Michael G. Erickson Executive Vice President | IDXX IDEXX Laboratories, Inc. | Sale | 204 | $625.24 | $127.5K Sale | Form 4 ↗ |
| Feb 17, 2026 | Michael G. Erickson Executive Vice President | IDXX IDEXX Laboratories, Inc. | Sale | 456 | $623.76 | $284.4K Sale | Form 4 ↗ |
| Feb 17, 2026 | Sophie V. Vandebroek Director | IDXX IDEXX Laboratories, Inc. | Sale | 519 | $628.56 | $326.2K Sale | Form 4 ↗ |
| Feb 17, 2026 | Sophie V. Vandebroek Director | IDXX IDEXX Laboratories, Inc. | Sale | 945 | $628.65 | $594.1K Sale | Form 4 ↗ |
| Feb 10, 2026 | George Fennell Executive Vice President | IDXX IDEXX Laboratories, Inc. | Sale | 40 | $650.32 | $26.0K Sale | Form 4 ↗ |
| Feb 10, 2026 | George Fennell Executive Vice President | IDXX IDEXX Laboratories, Inc. | Sale | 2,809 | $649.26 | $1.8M Sale | Form 4 ↗ |
| Feb 10, 2026 | George Fennell Executive Vice President | IDXX IDEXX Laboratories, Inc. | Sale | 966 | $648.78 | $626.7K Sale | Form 4 ↗ |
| Feb 10, 2026 | George Fennell Executive Vice President | IDXX IDEXX Laboratories, Inc. | Sale | 1,060 | $647.21 | $686.0K Sale | Form 4 ↗ |
| Feb 10, 2026 | George Fennell Executive Vice President | IDXX IDEXX Laboratories, Inc. | Sale | 2,782 | $646.23 | $1.8M Sale | Form 4 ↗ |
The newest 50 items, most recent first. Every row links to its original filing. Updated Nov 15, 2026, 7:00 PM EST.
Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.
Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Planned insider sales · Executive pay · Ownership stakes (13D / 13G) · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · 8-K events · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Patents · Clinical trial updates · FDA approvals and clearances